Finally, a number of gene expression profiles, comprised of genes for key chemokines such as CCL19, CCL21 and CXCL13, or a combined TH1 and B cell signature, have been utilized to determine the presence of TLS in tumor tissues (111, 112). The gene discussed is CCL21; the disease is neoplasm.